You just read:

Publication in EMBO Molecular Medicine Demonstrates CureVac's Proprietary mRNA Technology Enables Antibody Mediated Therapies Against Infectious Agents, Toxins and Tumors

News provided by

CureVac AG

Aug 15, 2017, 08:02 ET